Chemung Financial (CHMG) Financials

$83.92 0.00 (0.00%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$83.94 +0.02 (+0.03%)

As of 08/14/2026 07:34 PM Eastern

Annual Income Statements for Chemung Financial

This table shows Chemung Financial's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	9.43	10	13	20	16	19	26	29	25	24	15
Consolidated Net Income / (Loss)	9.43	10	7.43	20	16	19	26	29	25	24	15
Net Income / (Loss) Continuing Operations	9.43	10	13	20	16	19	26	29	25	24	15
Total Pre-Tax Income	14	14	15	24	19	24	34	37	32	30	20
Total Revenue	71	73	83	84	81	84	89	96	99	97	95
Net Interest Income / (Expense)	51	52	57	60	61	63	66	74	74	74	87
Total Interest Income	54	56	60	65	67	67	69	81	113	128	133
Loans and Leases Interest Income	48	50	53	58	58	59	59	68	97	112	120
Investment Securities Interest Income	5.90	6.18	6.65	5.96	6.42	7.06	10.00	13	15	14	9.50
Deposits and Money Market Investments Interest Income	0.08	0.31	0.56	0.76	2.27	0.75	0.15	0.26	0.53	1.40	2.96
Total Interest Expense	3.60	3.84	3.07	4.07	6.32	3.99	3.42	7.30	39	54	46
Deposits Interest Expense	2.00	2.17	2.17	3.32	6.17	3.83	3.28	6.66	36	50	42
Long-Term Debt Interest Expense	0.75	0.82	0.42	0.61	0.15	0.16	0.14	0.64	2.69	3.45	3.89
Total Non-Interest Income	20	21	20	23	20	21	24	21	25	23	7.95
Service Charges on Deposit Accounts	-	-	23	18	18	17	19	19	19	20	21
Other Service Charges	11	2.27	2.41	2.48	1.69	2.53	3.39	2.90	5.28	2.78	4.26
Net Realized & Unrealized Capital Gains on Investments	0.75	1.38	0.49	2.45	0.25	1.74	1.30	-0.18	0.25	0.38	-17
Other Non-Interest Income	0.08	18	0.07	0.07	0.06	0.16	0.05	0.05	0.04	0.04	0.03
Provision for Credit Losses	1.57	2.44	9.02	3.15	5.95	4.24	0.02	-0.55	3.26	-0.05	4.44
Total Non-Interest Expense	55	57	54	57	56	56	56	59	64	67	71
Salaries and Employee Benefits	27	26	27	28	29	30	30	33	34	37	39
Net Occupancy & Equipment Expense	17	16	16	16	16	16	16	16	17	18	18
Marketing Expense	0.90	0.88	0.79	1.18	0.93	0.63	0.79	0.94	0.92	1.18	1.25
Property & Liability Insurance Claims	1.08	2.39	2.09	2.13	0.54	0.99	1.41	1.36	2.13	2.12	1.52
Other Operating Expenses	8.62	10	7.41	8.78	8.44	8.49	6.68	7.88	9.79	9.82	11
Income Tax Expense	4.66	4.40	7.26	4.01	3.43	4.61	7.34	8.11	6.50	6.41	4.83
Basic Earnings per Share	$2.00	$2.11	$1.55	$4.06	$3.21	$4.01	$5.64	$6.13	$5.28	$4.96	$3.14
Weighted Average Basic Shares Outstanding	4.72M	4.76M	4.80M	4.83M	4.87M	4.80M	4.68M	4.69M	4.73M	4.77M	4.80M
Diluted Earnings per Share	$2.00	$2.11	$1.55	$4.06	$3.21	$4.01	$5.64	$6.13	$5.28	$4.96	$3.14
Weighted Average Diluted Shares Outstanding	4.72M	4.76M	4.80M	4.83M	4.87M	4.80M	4.68M	4.69M	4.73M	4.77M	4.80M
Weighted Average Basic & Diluted Shares Outstanding	4.72M	4.76M	4.80M	4.83M	4.87M	4.80M	4.67M	4.71M	4.75M	4.79M	4.82M
Cash Dividends to Common per Share	$1.04	$1.04	$1.04	$1.04	$1.04	$1.04	$1.19	$1.24	$1.24	$1.24	$1.32

This table shows Chemung Financial's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	3.80	7.05	4.99	5.72	5.91	6.02	-6.45	7.79	7.74	9.20	8.81
Consolidated Net Income / (Loss)	3.80	7.05	4.99	5.72	5.91	6.02	-6.45	7.79	7.74	9.20	8.81
Net Income / (Loss) Continuing Operations	3.80	7.05	4.99	5.72	5.91	6.02	-6.45	7.79	7.74	9.20	8.81
Total Pre-Tax Income	4.64	9.09	6.26	7.23	7.50	7.69	-8.81	10	11	12	11
Total Revenue	24	24	23	24	26	26	10	29	31	30	31
Net Interest Income / (Expense)	18	18	18	18	20	20	21	23	24	24	25
Total Interest Income	30	31	31	32	33	32	33	34	34	34	35
Loans and Leases Interest Income	26	27	28	29	29	28	29	31	32	32	33
Investment Securities Interest Income	3.79	3.82	3.51	3.31	3.41	3.27	2.74	1.73	1.75	1.76	1.74
Deposits and Money Market Investments Interest Income	0.13	0.21	0.37	0.44	0.38	0.33	0.86	1.12	0.67	0.30	0.33
Total Interest Expense	12	13	14	14	13	12	12	11	10	10	10
Deposits Interest Expense	11	12	13	13	12	11	11	10	9.39	8.54	8.70
Long-Term Debt Interest Expense	0.79	0.99	0.91	0.97	0.59	0.73	1.15	1.03	0.99	1.46	1.52
Total Non-Interest Income	5.87	5.66	5.60	5.92	6.06	5.89	-11	6.09	6.67	6.32	6.50
Service Charges on Deposit Accounts	4.88	4.72	4.97	5.13	5.23	5.02	5.22	5.13	5.30	5.21	5.34
Other Service Charges	0.74	0.80	0.57	0.59	0.81	0.88	1.41	0.73	1.25	1.15	0.84
Net Realized & Unrealized Capital Gains on Investments	0.24	0.13	0.05	0.19	0.00	-0.02	-17	0.21	0.12	-0.05	0.32
Other Non-Interest Income	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Provision for Credit Losses	2.30	-2.04	0.88	0.56	0.55	1.09	1.15	1.06	1.14	0.60	0.56
Total Non-Interest Expense	17	17	16	17	18	17	18	18	18	17	19
Salaries and Employee Benefits	8.70	9.10	8.90	8.80	9.75	9.13	9.69	10	10	9.72	10
Net Occupancy & Equipment Expense	4.40	4.46	4.14	4.39	4.59	4.44	4.45	4.30	4.37	4.47	4.66
Marketing Expense	0.20	0.35	0.39	0.21	0.24	0.34	0.35	0.20	0.36	0.24	0.50
Property & Liability Insurance Claims	0.52	0.58	0.52	0.52	0.50	0.44	0.43	0.35	0.29	0.32	0.30
Other Operating Expenses	3.00	2.21	2.28	2.59	2.75	2.58	2.84	2.56	2.96	2.71	3.54
Income Tax Expense	0.84	2.04	1.27	1.51	1.59	1.66	-2.36	2.28	3.25	2.64	2.48
Basic Earnings per Share	$0.80	$1.48	$1.05	$1.19	$1.24	$1.26	($1.35)	$1.62	$1.61	$1.91	$1.82
Weighted Average Basic Shares Outstanding	4.73M	4.76M	4.77M	4.77M	4.77M	4.79M	4.81M	4.81M	4.80M	4.82M	4.84M
Diluted Earnings per Share	$0.80	$1.48	$1.05	$1.19	$1.24	$1.26	($1.35)	$1.62	$1.61	$1.91	$1.82
Weighted Average Diluted Shares Outstanding	4.73M	4.76M	4.77M	4.77M	4.77M	4.79M	4.81M	4.81M	4.80M	4.82M	4.84M
Weighted Average Basic & Diluted Shares Outstanding	4.75M	4.75M	4.76M	4.76M	4.79M	4.79M	4.79M	4.79M	4.82M	4.82M	4.82M

This table details how cash moves in and out of Chemung Financial's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-2.98	48	-43	99	-8.07	-13	-82	29	-19	10	3.06
Net Cash From Operating Activities	14	22	24	28	26	29	35	35	31	30	45
Net Cash From Continuing Operating Activities	14	22	24	28	26	29	35	35	31	30	45
Net Income / (Loss) Continuing Operations	9.43	10	7.43	20	16	19	26	29	25	24	15
Consolidated Net Income / (Loss)	9.43	10	7.43	20	16	19	26	29	25	24	15
Provision For Loan Losses	1.96	2.44	9.02	3.15	5.95	4.24	0.02	-0.55	3.43	-0.05	4.44
Depreciation Expense	4.04	4.21	3.70	3.44	3.11	2.92	2.50	2.23	2.00	1.81	1.90
Amortization Expense	3.04	2.77	2.35	2.04	2.38	3.18	6.38	4.56	3.26	2.46	2.27
Non-Cash Adjustments to Reconcile Net Income	0.16	-2.52	4.38	2.74	-2.09	0.71	-0.74	1.92	-2.35	1.96	14
Changes in Operating Assets and Liabilities, net	-4.52	5.23	-3.15	-3.22	1.46	-1.66	0.88	-1.89	-0.45	-0.05	7.41
Net Cash From Investing Activities	-115	-0.73	-107	44	-33	-496	-242	-253	-82	-58	68
Net Cash From Continuing Investing Activities	-115	-0.73	-107	44	-33	-496	-242	-253	-82	-58	68
Purchase of Property, Leasehold Improvements and Equipment	-1.15	-1.70	-1.48	-1.77	-0.88	-0.87	-0.37	-0.43	-0.46	-3.63	-1.69
Purchase of Investment Securities	-250	-139	-166	-46	-119	-571	-389	-373	-247	-137	-223
Sale and/or Maturity of Investments	136	140	61	92	87	76	147	121	165	83	293
Net Cash From Financing Activities	98	27	40	28	-1.76	454	125	246	32	38	-111
Net Cash From Continuing Financing Activities	98	27	40	28	-1.76	454	125	246	32	38	-111
Net Change in Deposits	120	56	11	102	2.90	466	118	172	102	-33	-126
Issuance of Debt	-	-	58	-	-	-	-	-	-	0.00	45
Issuance of Common Equity	0.44	0.44	0.58	0.64	0.59	1.02	0.43	0.42	0.60	0.43	0.54
Repayment of Debt	-17	-24	-7.30	-60	-0.22	-0.24	14	81	-64	77	-23
Repurchase of Common Equity	-	-	-	0.00	0.00	-7.59	-1.62	-0.93	-0.32	-0.34	-0.40
Payment of Dividends	-4.83	-4.88	-4.92	-4.97	-5.03	-5.01	-5.32	-5.80	-5.84	-7.37	-6.33
Other Financing Activities, Net	-1.20	-0.85	-18	-10	0.00	-	-	-	-0.28	0.73	-0.34
Cash Interest Paid	3.63	3.84	3.13	3.99	6.25	4.03	3.47	6.64	37	53	47
Cash Income Taxes Paid	7.05	4.36	4.05	1.73	4.46	6.01	5.68	5.63	7.86	6.08	6.35

This table details how cash moves in and out of Chemung Financial's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	-39	58	-25	10	-33	6.40	267	-212	-58	3.27	20
Net Cash From Operating Activities	3.62	7.93	6.49	9.16	6.24	7.18	9.75	12	16	9.04	9.24
Net Cash From Continuing Operating Activities	3.62	7.93	6.49	9.16	6.24	7.18	9.75	12	16	9.04	9.24
Net Income / (Loss) Continuing Operations	3.80	7.05	4.99	5.72	5.91	6.02	-6.45	7.79	7.74	9.20	8.81
Consolidated Net Income / (Loss)	3.80	7.05	4.99	5.72	5.91	6.02	-6.45	7.79	7.74	9.20	8.81
Provision For Loan Losses	2.46	-2.04	0.88	0.56	0.55	1.09	1.15	1.06	1.14	0.60	0.56
Depreciation Expense	0.47	0.47	0.47	0.42	0.46	0.47	0.47	0.46	0.49	0.48	0.49
Amortization Expense	0.78	0.14	0.80	0.87	0.66	0.70	0.70	0.40	0.46	0.40	0.43
Non-Cash Adjustments to Reconcile Net Income	-2.53	0.47	-0.18	0.39	1.28	-0.11	15	-0.97	0.44	-0.48	0.35
Changes in Operating Assets and Liabilities, net	-1.37	1.85	-0.47	1.19	-2.62	-0.99	-1.16	3.49	6.06	-1.16	-1.40
Net Cash From Investing Activities	-29	-18	4.23	-1.21	-43	-12	209	-58	-71	-36	-52
Net Cash From Continuing Investing Activities	-29	-18	4.23	-1.21	-43	-12	209	-58	-71	-36	-52
Purchase of Property, Leasehold Improvements and Equipment	-0.00	-0.08	-1.02	-0.61	-1.92	-0.33	-0.36	-0.40	-0.60	-0.13	-0.32
Purchase of Investment Securities	-99	-42	-16	-16	-63	-34	-38	-71	-79	-49	-62
Sale and/or Maturity of Investments	71	24	21	16	22	23	247	14	8.43	13	10
Net Cash From Financing Activities	-14	68	-35	2.27	3.24	11	48	-167	-2.67	30	62
Net Cash From Continuing Financing Activities	-14	68	-35	2.27	3.24	11	48	-167	-2.67	30	62
Net Change in Deposits	-44	51	-65	35	-54	37	36	-110	-88	43	50
Issuance of Common Equity	0.09	0.15	0.10	0.11	0.08	0.15	0.08	0.23	0.07	0.16	0.10
Repayment of Debt	32	-32	80	-30	76	-24	-31	-55	87	-11	-33
Repurchase of Common Equity	-0.22	-0.08	-	-0.01	-0.25	-0.09	-0.01	-0.01	-0.30	-0.17	-0.01
Payment of Dividends	-1.46	-1.47	-1.47	-2.95	-1.48	-1.53	-1.53	-1.63	-1.63	-1.64	-1.64
Cash Interest Paid	13	11	13	13	16	12	12	13	11	9.41	11
Cash Income Taxes Paid	1.83	0.46	2.83	1.38	1.43	0.44	3.28	0.10	2.53	0.12	6.44

This table presents Chemung Financial's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,620	1,657	1,708	1,755	1,788	2,279	2,418	2,646	2,711	2,776	2,710
Cash and Due from Banks	25	28	28	33	25	29	44	29	22	26	23
Interest Bearing Deposits at Other Banks	1.30	46	2.76	97	97	79	9.62	27	15	21	27
Trading Account Securities	351	309	297	248	291	557	808	662	609	556	299
Loans and Leases, Net of Allowance	1,154	1,186	1,291	1,293	1,286	1,516	-21	1,810	1,950	2,050	2,245
Loans and Leases	1,169	1,200	1,312	1,312	1,309	1,536	-	1,829	1,973	2,071	2,270
Allowance for Loan and Lease Losses	14	14	21	19	23	21	21	20	23	21	24
Loans Held for Sale	-	-	-	-	-	0.17	0.40	-	0.00	0.00	2.10
Premises and Equipment, Net	29	29	27	25	22	20	18	16	15	16	15
Goodwill	22	22	22	22	22	22	22	22	22	22	22
Other Assets	33	34	38	37	45	56	1,528	80	78	85	77
Total Liabilities & Shareholders' Equity	1,620	1,657	1,708	1,755	1,788	2,279	2,418	2,646	2,711	2,776	2,710
Total Liabilities	1,483	1,513	1,558	1,590	1,605	2,080	2,163	2,479	2,515	2,561	2,456
Non-Interest Bearing Deposits	402	418	468	484	468	620	740	733	653	626	625
Interest Bearing Deposits	998	1,039	1,000	1,085	1,104	1,417	1,416	1,594	1,776	1,771	1,646
Long-Term Debt	19	9.09	2.00	-	-	0.00	-	96	32	109	131
Capital Lease Obligations	2.87	4.72	4.52	4.30	4.09	3.85	-	3.33	3.05	3.78	3.44
Other Long-Term Liabilities	17	14	15	16	29	37	7.38	51	49	51	50
Total Equity & Noncontrolling Interests	137	144	150	165	183	200	211	166	195	215	255
Total Preferred & Common Equity	137	144	150	165	183	200	211	166	195	215	255
Total Common Equity	137	144	150	165	183	200	211	166	195	215	255
Common Stock	46	46	46	46	46	47	47	47	48	49	50
Retained Earnings	119	124	128	143	154	168	189	212	230	248	256
Treasury Stock	-16	-15	-14	-13	-12	-18	-18	-18	-17	-16	-15
Accumulated Other Comprehensive Income / (Loss)	-11	-11	-10	-11	-5.80	2.40	-6.53	-75	-66	-65	-36

This table presents Chemung Financial's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	2,708	2,785	2,756	2,774	2,797	2,852	2,697	2,749	2,820
Cash and Due from Banks	53	23	23	36	32	36	32	28	29
Interest Bearing Deposits at Other Banks	23	72	47	44	21	284	75	26	44
Trading Account Securities	604	593	577	575	550	307	299	293	288
Loans and Leases, Net of Allowance	1,910	1,983	1,990	2,008	2,075	2,110	2,179	2,287	2,342
Loans and Leases	1,931	2,004	2,011	2,029	2,098	2,132	2,202	2,312	2,367
Allowance for Loan and Lease Losses	20	20	21	21	23	23	24	25	25
Loans Held for Sale	-	0.10	0.38	-	0.28	2.21	3.08	2.71	2.43
Premises and Equipment, Net	15	14	15	15	16	15	15	15	15
Goodwill	22	22	22	22	22	22	22	22	22
Other Assets	81	78	81	75	80	76	71	76	78
Total Liabilities & Shareholders' Equity	2,708	2,785	2,756	2,774	2,797	2,852	2,697	2,749	2,820
Total Liabilities	2,538	2,588	2,555	2,554	2,568	2,618	2,451	2,486	2,550
Non-Interest Bearing Deposits	683	656	619	616	620	624	633	641	682
Interest Bearing Deposits	1,790	1,824	1,797	1,835	1,814	1,845	1,725	1,673	1,682
Long-Term Debt	0.00	50	80	50	85	99	44	120	134
Capital Lease Obligations	3.12	2.98	3.84	3.76	3.70	3.62	3.53	3.36	3.27
Other Long-Term Liabilities	60	54	53	49	46	46	45	49	49
Total Equity & Noncontrolling Interests	170	197	201	221	228	235	245	263	270
Total Preferred & Common Equity	170	197	201	221	228	235	245	263	270
Total Common Equity	170	197	201	221	228	235	245	263	270
Common Stock	48	48	48	49	48	49	49	49	50
Retained Earnings	228	236	239	243	252	244	250	264	271
Treasury Stock	-17	-16	-16	-16	-15	-15	-15	-15	-15
Accumulated Other Comprehensive Income / (Loss)	-89	-70	-70	-55	-57	-43	-39	-36	-36

This table displays calculated financial ratios and metrics derived from Chemung Financial's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	4,661,226.00	4,703,034.00	4,740,401.00	4,806,864.00	4,846,630.00	4,656,862.00	4,664,078.00	4,678,083.00	4,722,636.00	-	4,794,349.00
DEI Adjusted Shares Outstanding	4,661,226.00	4,703,034.00	4,740,401.00	4,806,864.00	4,846,630.00	4,656,862.00	4,664,078.00	4,678,083.00	4,722,636.00	-	4,794,349.00
DEI Earnings Per Adjusted Shares Outstanding	2.02	2.13	1.57	4.08	3.22	4.14	5.67	6.15	5.29	-	3.15
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.86%	3.36%	13.07%	0.56%	-3.43%	4.16%	6.44%	6.88%	3.55%	-1.73%	-2.25%
EBITDA Growth	8.95%	1.10%	23.09%	10.48%	-15.73%	22.17%	42.27%	2.44%	-15.83%	-6.53%	-29.87%
EBIT Growth	18.75%	2.41%	40.66%	16.43%	-19.43%	25.34%	41.44%	9.27%	-14.61%	-4.50%	-33.73%
NOPAT Growth	15.64%	6.30%	-25.90%	164.15%	-20.47%	23.40%	37.19%	8.92%	-13.14%	-5.32%	-36.19%
Net Income Growth	15.64%	6.30%	-25.90%	164.15%	-20.47%	23.40%	37.19%	8.92%	-13.14%	-5.32%	-36.19%
EPS Growth	14.94%	5.50%	-26.54%	161.94%	-20.94%	24.92%	40.65%	8.69%	-13.87%	-6.06%	-36.69%
Operating Cash Flow Growth	-23.42%	56.77%	6.79%	17.45%	-4.92%	8.54%	23.73%	-1.17%	-11.89%	-3.45%	52.60%
Free Cash Flow Firm Growth	306.18%	9.81%	-218.48%	336.46%	-102.38%	237.06%	-1,158.99%	173.65%	218.75%	-223.22%	38.12%
Invested Capital Growth	-6.80%	-8.18%	20.99%	-24.42%	10.26%	9.02%	25.60%	3.86%	-13.30%	42.56%	18.61%
Revenue Q/Q Growth	-8.32%	0.28%	23.97%	-10.08%	-6.67%	4.02%	0.34%	3.92%	-2.48%	2.21%	5.13%
EBITDA Q/Q Growth	-16.32%	4.60%	71.30%	-19.98%	-14.53%	11.85%	4.64%	1.08%	-11.92%	8.62%	16.00%
EBIT Q/Q Growth	-21.49%	8.19%	119.85%	-23.28%	-17.76%	11.77%	5.32%	3.61%	-13.40%	10.51%	21.22%
NOPAT Q/Q Growth	-19.96%	8.97%	-53.89%	140.34%	-8.91%	5.64%	4.84%	3.54%	-12.70%	9.80%	13.76%
Net Income Q/Q Growth	-19.96%	8.97%	-53.89%	140.34%	-8.91%	5.64%	4.84%	3.54%	-12.70%	9.80%	13.76%
EPS Q/Q Growth	-20.32%	8.76%	-40.84%	67.77%	-9.07%	0.00%	0.00%	3.37%	-12.87%	9.73%	13.36%
Operating Cash Flow Q/Q Growth	-12.35%	-7.15%	24.81%	2.23%	-10.42%	16.58%	0.60%	-15.69%	4.25%	9.61%	28.52%
Free Cash Flow Firm Q/Q Growth	32.45%	1,453.22%	-185.02%	195.37%	56.32%	374.75%	-227.03%	-74.54%	300.09%	6.72%	-792.64%
Invested Capital Q/Q Growth	5.47%	-6.81%	25.96%	5.27%	2.56%	1.19%	24.03%	66.35%	32.93%	19.60%	32.94%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	29.79%	29.13%	31.71%	34.84%	30.40%	35.66%	47.66%	45.68%	37.13%	35.32%	25.34%
EBIT Margin	19.82%	19.64%	24.43%	28.29%	23.60%	28.40%	37.74%	38.58%	31.82%	30.92%	20.96%
Profit (Net Income) Margin	13.27%	13.65%	8.94%	23.49%	19.35%	22.92%	29.54%	30.10%	25.25%	24.33%	15.88%
Tax Burden Percent	66.94%	69.48%	50.57%	83.04%	81.97%	80.70%	78.27%	78.03%	79.36%	78.68%	75.76%
Interest Burden Percent	100.00%	100.00%	72.38%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	33.06%	30.52%	49.43%	16.96%	18.03%	19.30%	21.73%	21.97%	20.64%	21.32%	24.24%
Return on Invested Capital (ROIC)	4.51%	5.18%	3.63%	9.98%	8.77%	9.87%	11.51%	11.05%	10.09%	8.48%	4.21%
ROIC Less NNEP Spread (ROIC-NNEP)	4.51%	5.18%	3.63%	9.98%	8.77%	9.87%	11.51%	11.05%	10.09%	8.48%	4.21%
Return on Net Nonoperating Assets (RNNOA)	2.45%	1.95%	1.43%	2.49%	0.21%	0.20%	1.35%	4.19%	3.74%	3.05%	2.22%
Return on Equity (ROE)	6.97%	7.14%	5.06%	12.47%	8.98%	10.08%	12.85%	15.24%	13.83%	11.53%	6.43%
Cash Return on Invested Capital (CROIC)	11.56%	13.72%	-15.36%	37.79%	-0.99%	1.24%	-11.19%	7.26%	24.33%	-26.62%	-12.82%
Operating Return on Assets (OROA)	0.90%	0.88%	1.21%	1.37%	1.07%	1.17%	1.44%	1.46%	1.18%	1.10%	0.73%
Return on Assets (ROA)	0.60%	0.61%	0.44%	1.13%	0.88%	0.95%	1.13%	1.14%	0.93%	0.86%	0.55%
Return on Common Equity (ROCE)	6.97%	7.14%	5.06%	12.47%	8.98%	10.08%	12.85%	15.24%	13.83%	11.53%	6.43%
Return on Equity Simple (ROE_SIMPLE)	6.87%	6.98%	4.96%	11.89%	8.55%	9.65%	12.50%	17.30%	12.80%	10.99%	5.93%
Net Operating Profit after Tax (NOPAT)	9.43	10	7.43	20	16	19	26	29	25	24	15
NOPAT Margin	13.27%	13.65%	8.94%	23.49%	19.35%	22.92%	29.54%	30.10%	25.25%	24.33%	15.88%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	62.74%	58.63%	52.25%	54.01%	57.14%	54.70%	52.93%	52.32%	52.85%	56.85%	61.27%
Operating Expenses to Revenue	77.97%	77.04%	64.71%	67.94%	69.03%	66.56%	62.24%	62.00%	64.89%	69.12%	74.37%
Earnings before Interest and Taxes (EBIT)	14	14	20	24	19	24	34	37	32	30	20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	21	21	26	29	25	30	43	44	37	34	24
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.73	0.97	1.27	1.03	0.99	0.72	0.95	1.24	1.17	1.08	1.04
Price to Tangible Book Value (P/TBV)	0.90	1.17	1.51	1.19	1.12	0.81	1.06	1.42	1.32	1.20	1.14
Price to Revenue (P/Rev)	1.42	1.89	2.29	2.03	2.23	1.70	2.25	2.15	2.31	2.39	2.79
Price to Earnings (P/E)	10.67	13.87	14.58	8.64	11.53	7.44	7.63	7.14	9.15	9.81	17.60
Dividend Yield	4.81%	3.52%	2.59%	2.95%	2.80%	3.38%	2.75%	2.82%	2.56%	2.54%	2.38%
Earnings Yield	9.37%	7.21%	6.86%	11.58%	8.68%	13.44%	13.10%	14.01%	10.92%	10.19%	5.68%
Enterprise Value to Invested Capital (EV/IC)	0.69	0.57	1.04	0.26	0.33	0.19	0.58	0.94	0.99	0.91	0.90
Enterprise Value to Revenue (EV/Rev)	1.95	1.45	2.81	0.52	0.77	0.46	1.65	2.60	2.29	3.06	3.68
Enterprise Value to EBITDA (EV/EBITDA)	6.56	4.97	8.87	1.51	2.53	1.29	3.47	5.70	6.17	8.68	14.54
Enterprise Value to EBIT (EV/EBIT)	9.86	7.37	11.51	1.85	3.26	1.62	4.38	6.74	7.21	9.91	17.57
Enterprise Value to NOPAT (EV/NOPAT)	14.73	10.60	31.44	2.23	3.98	2.00	5.59	8.64	9.08	12.59	23.19
Enterprise Value to Operating Cash Flow (EV/OCF)	9.84	4.80	9.88	1.58	2.35	1.35	4.17	7.10	7.35	10.00	7.70
Enterprise Value to Free Cash Flow (EV/FCFF)	5.75	4.01	0.00	0.59	0.00	15.91	0.00	13.15	3.76	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.47	0.29	0.50	0.03	0.02	0.02	0.00	0.60	0.18	0.52	0.53
Long-Term Debt to Equity	0.16	0.10	0.04	0.03	0.02	0.02	0.00	0.60	0.18	0.52	0.53
Financial Leverage	0.54	0.38	0.39	0.25	0.02	0.02	0.12	0.38	0.37	0.36	0.53
Leverage Ratio	11.61	11.66	11.46	11.00	10.19	10.64	11.43	13.40	14.81	13.36	11.67
Compound Leverage Factor	11.61	11.66	8.30	11.00	10.19	10.64	11.43	13.40	14.81	13.36	11.67
Debt to Total Capital	31.95%	22.37%	33.13%	2.54%	2.19%	1.89%	0.00%	37.34%	15.19%	34.40%	34.57%
Short-Term Debt to Total Capital	21.00%	14.91%	30.22%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	10.95%	7.46%	2.91%	2.54%	2.19%	1.89%	0.00%	37.34%	15.19%	34.40%	34.57%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	68.05%	77.63%	66.87%	97.46%	97.81%	98.11%	100.00%	62.66%	84.81%	65.60%	65.43%
Debt to EBITDA	3.04	1.93	2.82	0.15	0.17	0.13	0.00	2.27	0.95	3.29	5.59
Net Debt to EBITDA	1.81	-1.53	1.65	-4.32	-4.80	-3.49	0.00	0.99	-0.05	1.92	3.51
Long-Term Debt to EBITDA	1.04	0.65	0.25	0.15	0.17	0.13	0.00	2.27	0.95	3.29	5.59
Debt to NOPAT	6.83	4.13	9.99	0.22	0.26	0.20	0.00	3.44	1.40	4.77	8.91
Net Debt to NOPAT	4.05	-3.27	5.85	-6.40	-7.55	-5.44	0.00	1.50	-0.08	2.78	5.59
Long-Term Debt to NOPAT	2.34	1.38	0.88	0.22	0.26	0.20	0.00	3.44	1.40	4.77	8.91
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	24	27	-31	74	-1.77	2.43	-26	19	60	-74	-46
Operating Cash Flow to CapEx	1,223.83%	1,305.48%	1,595.48%	1,569.04%	2,990.37%	3,305.54%	9,662.40%	8,227.00%	6,684.20%	822.26%	2,697.04%
Free Cash Flow to Firm to Interest Expense	6.71	6.91	-10.24	18.25	-0.28	0.61	-7.51	2.59	1.56	-1.39	-1.01
Operating Cash Flow to Interest Expense	3.92	5.77	7.71	6.82	4.18	7.19	10.37	4.80	0.80	0.56	1.00
Operating Cash Flow Less CapEx to Interest Expense	3.60	5.33	7.22	6.38	4.04	6.97	10.26	4.75	0.79	0.49	0.96
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.05	0.04	0.05	0.05	0.05	0.04	0.04	0.04	0.04	0.04	0.03
Fixed Asset Turnover	2.30	2.52	2.99	3.24	3.40	3.95	4.70	5.61	6.45	6.29	5.99
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	202	185	224	169	187	204	256	266	230	328	389
Invested Capital Turnover	0.34	0.38	0.41	0.42	0.45	0.43	0.39	0.37	0.40	0.35	0.27
Increase / (Decrease) in Invested Capital	-15	-17	39	-55	17	17	52	9.86	-35	98	61
Enterprise Value (EV)	139	106	234	44	62	39	148	249	227	298	350
Market Capitalization	101	139	190	169	180	143	202	205	229	232	266
Book Value per Share	$29.44	$30.57	$31.60	$34.33	$37.68	$42.88	$45.34	$35.57	$41.34	$45.25	$53.13
Tangible Book Value per Share	$23.92	$25.30	$26.56	$29.51	$33.03	$38.14	$40.65	$30.90	$36.72	$40.66	$48.57
Total Capital	202	185	224	169	187	204	211	266	230	328	389
Total Debt	64	41	74	4.30	4.09	3.85	0.00	99	35	113	135
Total Long-Term Debt	22	14	6.52	4.30	4.09	3.85	0.00	99	35	113	135
Net Debt	38	-33	43	-126	-118	-105	-54	43	-1.88	66	84
Capital Expenditures (CapEx)	1.15	1.70	1.48	1.77	0.88	0.87	0.37	0.43	0.46	3.63	1.69
Net Nonoperating Expense (NNE)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Nonoperating Obligations (NNO)	64	41	74	4.30	4.09	3.85	44	99	35	113	135
Total Depreciation and Amortization (D&A)	7.08	6.98	6.05	5.48	5.49	6.10	8.88	6.79	5.26	4.28	4.16
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.00	$2.11	$1.55	$4.06	$3.21	$4.01	$5.64	$6.13	$5.28	$4.96	$3.14
Adjusted Weighted Average Basic Shares Outstanding	4.69M	4.73M	4.76M	4.84M	4.87M	4.66M	4.68M	4.69M	4.73M	4.77M	4.80M
Adjusted Diluted Earnings per Share	$2.00	$2.11	$1.55	$4.06	$3.21	$4.01	$5.64	$6.13	$5.28	$4.96	$3.14
Adjusted Weighted Average Diluted Shares Outstanding	4.69M	4.73M	4.76M	4.84M	4.87M	4.66M	4.68M	4.69M	4.73M	4.77M	4.80M
Adjusted Basic & Diluted Earnings per Share	$2.00	$2.11	$1.55	$4.06	$3.21	$4.01	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.72M	4.76M	4.80M	4.83M	4.87M	4.80M	4.67M	4.71M	4.75M	4.79M	4.82M
Normalized Net Operating Profit after Tax (NOPAT)	9.43	10	7.43	20	16	19	26	29	25	24	15
Normalized NOPAT Margin	13.27%	13.63%	8.94%	23.49%	19.35%	22.92%	29.54%	30.10%	25.25%	24.33%	15.88%
Pre Tax Income Margin	19.82%	19.64%	17.68%	28.29%	23.60%	28.40%	37.74%	38.58%	31.82%	30.92%	20.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.91	3.76	6.62	5.80	3.01	5.99	9.87	5.06	0.82	0.56	0.44
NOPAT to Interest Expense	2.62	2.61	2.42	4.82	2.47	4.83	7.73	3.95	0.65	0.44	0.33
EBIT Less CapEx to Interest Expense	3.59	3.32	6.13	5.37	2.87	5.77	9.77	5.00	0.80	0.49	0.40
NOPAT Less CapEx to Interest Expense	2.30	2.17	1.94	4.38	2.33	4.61	7.62	3.89	0.64	0.37	0.29
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	51.24%	48.65%	66.18%	25.32%	32.22%	25.99%	20.12%	20.14%	23.36%	31.11%	41.88%
Augmented Payout Ratio	51.24%	48.65%	66.18%	25.32%	32.22%	65.39%	26.24%	23.38%	24.62%	32.57%	44.50%

This table displays calculated financial ratios and metrics derived from Chemung Financial's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	4,722,636.00	4,750,674.00	4,752,375.00	4,756,024.00	-	4,788,879.00	4,790,325.00	4,790,939.00	4,794,349.00	4,818,467.00	4,819,820.00
DEI Adjusted Shares Outstanding	4,722,636.00	4,750,674.00	4,752,375.00	4,756,024.00	-	4,788,879.00	4,790,325.00	4,790,939.00	4,794,349.00	4,818,467.00	4,819,820.00
DEI Earnings Per Adjusted Shares Outstanding	0.81	1.48	1.05	1.20	-	1.26	-1.35	1.63	1.61	1.91	1.83
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-9.59%	-6.40%	-2.84%	-5.88%	8.87%	8.25%	-56.75%	18.39%	17.93%	16.33%	208.55%
EBITDA Growth	-45.79%	-8.94%	-18.49%	-22.47%	46.31%	-8.61%	-201.41%	28.26%	38.55%	43.66%	259.91%
EBIT Growth	-51.21%	-1.83%	-20.68%	-25.49%	61.60%	-15.42%	-240.73%	39.18%	46.51%	54.04%	228.15%
NOPAT Growth	-48.89%	-3.03%	-20.59%	-25.21%	55.55%	-14.57%	-223.68%	36.22%	30.89%	52.73%	242.84%
Net Income Growth	-48.89%	-3.03%	-20.59%	-25.21%	55.55%	-14.57%	-229.38%	36.22%	30.89%	52.73%	236.55%
EPS Growth	-49.37%	-3.90%	-21.05%	-26.09%	55.00%	-14.86%	-228.57%	36.13%	29.84%	51.59%	234.81%
Operating Cash Flow Growth	53.26%	-25.75%	-9.63%	-2.53%	72.24%	-9.50%	50.22%	33.65%	161.96%	25.88%	-5.24%
Free Cash Flow Firm Growth	1,715.03%	160.72%	-4,433.99%	-1,514.93%	-335.38%	-184.24%	-20.83%	88.86%	42.05%	1.70%	-3.26%
Invested Capital Growth	-13.30%	-20.68%	23.20%	58.45%	42.56%	26.75%	18.48%	6.72%	18.61%	21.78%	20.60%
Revenue Q/Q Growth	-7.96%	-0.10%	-1.63%	4.06%	6.46%	-0.66%	-60.70%	184.83%	6.05%	-2.01%	4.24%
EBITDA Q/Q Growth	-46.40%	64.54%	-22.35%	13.21%	1.15%	2.77%	-186.17%	243.18%	9.27%	6.56%	-4.08%
EBIT Q/Q Growth	-52.17%	95.74%	-31.11%	15.52%	3.73%	2.45%	-214.62%	214.25%	9.20%	7.71%	-4.64%
NOPAT Q/Q Growth	-50.29%	85.43%	-29.26%	14.70%	3.39%	1.84%	-202.40%	226.34%	-0.65%	18.83%	-4.23%
Net Income Q/Q Growth	-50.29%	85.43%	-29.26%	14.70%	3.39%	1.84%	-207.12%	220.77%	-0.65%	18.83%	-4.23%
EPS Q/Q Growth	-50.31%	85.00%	-29.05%	13.33%	4.20%	1.61%	-207.14%	220.00%	-0.62%	18.63%	-4.71%
Operating Cash Flow Q/Q Growth	-61.47%	119.17%	-18.23%	41.15%	-31.92%	15.16%	35.74%	25.59%	33.44%	-44.66%	2.18%
Free Cash Flow Firm Q/Q Growth	761.41%	84.76%	-167.38%	-96.13%	3.60%	33.88%	3.35%	81.92%	-401.57%	-12.17%	-1.53%
Invested Capital Q/Q Growth	32.93%	8.64%	13.97%	-3.73%	19.60%	-3.41%	6.54%	-13.29%	32.94%	-0.83%	5.50%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	24.78%	40.82%	32.22%	35.06%	33.31%	34.46%	-75.55%	37.98%	39.13%	42.55%	39.16%
EBIT Margin	19.53%	38.27%	26.80%	29.76%	28.99%	29.90%	-87.21%	34.98%	36.02%	39.60%	36.22%
Profit (Net Income) Margin	16.00%	29.69%	21.35%	23.53%	22.85%	23.43%	-63.86%	27.08%	25.37%	30.76%	28.26%
Tax Burden Percent	81.89%	77.57%	79.65%	79.08%	78.82%	78.35%	73.23%	77.40%	70.42%	77.69%	78.03%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	18.11%	22.43%	20.35%	20.92%	21.18%	21.65%	0.00%	22.60%	29.58%	22.31%	21.97%
Return on Invested Capital (ROIC)	6.39%	10.23%	8.00%	10.01%	7.96%	8.20%	-16.86%	8.64%	6.72%	8.69%	9.13%
ROIC Less NNEP Spread (ROIC-NNEP)	6.39%	10.23%	8.00%	10.01%	7.96%	8.20%	-17.16%	8.64%	6.72%	8.69%	9.13%
Return on Net Nonoperating Assets (RNNOA)	2.37%	5.22%	2.91%	1.46%	2.87%	2.73%	-7.34%	1.88%	3.54%	3.75%	4.33%
Return on Equity (ROE)	8.76%	15.44%	10.90%	11.47%	10.83%	10.93%	-24.20%	10.51%	10.27%	12.44%	13.46%
Cash Return on Invested Capital (CROIC)	24.33%	31.83%	-11.69%	-35.60%	-26.62%	-15.61%	-13.32%	-1.82%	-12.82%	-14.44%	-9.67%
Operating Return on Assets (OROA)	0.72%	1.37%	0.95%	1.03%	1.03%	1.06%	-2.67%	1.16%	1.25%	1.42%	1.54%
Return on Assets (ROA)	0.59%	1.06%	0.76%	0.82%	0.81%	0.83%	-1.96%	0.90%	0.88%	1.10%	1.20%
Return on Common Equity (ROCE)	8.76%	15.44%	10.90%	11.47%	10.83%	10.93%	-24.20%	10.51%	10.27%	12.44%	13.46%
Return on Equity Simple (ROE_SIMPLE)	0.00%	12.57%	11.67%	9.77%	0.00%	9.92%	4.77%	5.41%	0.00%	6.95%	12.41%
Net Operating Profit after Tax (NOPAT)	3.80	7.05	4.99	5.72	5.91	6.02	-6.17	7.79	7.74	9.20	8.81
NOPAT Margin	16.00%	29.69%	21.35%	23.53%	22.85%	23.43%	-61.05%	27.08%	25.37%	30.76%	28.26%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.30%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	55.97%	58.57%	57.49%	55.11%	56.32%	54.11%	143.43%	51.19%	49.60%	48.27%	49.66%
Operating Expenses to Revenue	70.79%	70.32%	69.43%	67.92%	68.88%	65.85%	175.88%	61.32%	60.25%	58.39%	61.98%
Earnings before Interest and Taxes (EBIT)	4.64	9.09	6.26	7.23	7.50	7.69	-8.81	10	11	12	11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5.89	9.69	7.53	8.52	8.62	8.86	-7.63	11	12	13	12
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.17	1.00	1.10	1.01	1.08	0.97	0.99	1.03	1.04	0.99	1.33
Price to Tangible Book Value (P/TBV)	1.32	1.12	1.24	1.12	1.20	1.08	1.09	1.13	1.14	1.08	1.45
Price to Revenue (P/Rev)	2.31	2.02	2.30	2.34	2.39	2.24	2.70	2.78	2.79	2.61	2.99
Price to Earnings (P/E)	9.15	7.93	9.46	10.32	9.81	9.81	20.72	18.95	17.60	14.19	10.72
Dividend Yield	2.56%	3.00%	2.65%	2.65%	2.54%	2.70%	2.60%	2.46%	2.38%	2.49%	1.82%
Earnings Yield	10.92%	12.61%	10.57%	9.69%	10.19%	10.20%	4.83%	5.28%	5.68%	7.05%	9.33%
Enterprise Value to Invested Capital (EV/IC)	0.99	0.62	0.83	0.71	0.91	0.81	0.04	0.65	0.90	0.85	1.04
Enterprise Value to Revenue (EV/Rev)	2.29	1.59	2.44	2.06	3.06	2.59	0.17	2.12	3.68	3.31	3.52
Enterprise Value to EBITDA (EV/EBITDA)	6.17	4.32	6.92	6.19	8.68	7.68	0.81	9.22	14.54	11.77	8.85
Enterprise Value to EBIT (EV/EBIT)	7.21	4.94	7.94	7.19	9.91	8.97	1.09	11.64	17.57	13.66	9.58
Enterprise Value to NOPAT (EV/NOPAT)	9.08	6.24	10.04	9.08	12.59	11.36	1.33	14.42	23.19	18.00	12.62
Enterprise Value to Operating Cash Flow (EV/OCF)	7.35	5.50	8.60	7.20	10.00	8.85	0.46	5.41	7.70	6.95	9.04
Enterprise Value to Free Cash Flow (EV/FCFF)	3.76	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.18	0.27	0.42	0.24	0.52	0.39	0.44	0.19	0.53	0.47	0.51
Long-Term Debt to Equity	0.18	0.27	0.42	0.24	0.52	0.39	0.44	0.19	0.53	0.47	0.51
Financial Leverage	0.37	0.51	0.36	0.15	0.36	0.33	0.43	0.22	0.53	0.43	0.47
Leverage Ratio	14.81	14.52	14.34	14.03	13.36	13.12	12.86	11.74	11.67	11.29	11.23
Compound Leverage Factor	14.81	14.52	14.34	14.03	13.36	13.12	12.86	11.74	11.67	11.29	11.23
Debt to Total Capital	15.19%	21.18%	29.41%	19.59%	34.40%	27.98%	30.43%	16.23%	34.57%	31.89%	33.62%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	15.19%	21.18%	29.41%	19.59%	34.40%	27.98%	30.43%	16.23%	34.57%	31.89%	33.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	84.81%	78.82%	70.59%	80.41%	65.60%	72.02%	69.57%	83.77%	65.43%	68.11%	66.38%
Debt to EBITDA	0.95	1.48	2.46	1.70	3.29	2.65	5.60	2.29	5.59	4.40	2.86
Net Debt to EBITDA	-0.05	-1.17	0.40	-0.84	1.92	1.05	-11.83	-2.89	3.51	2.49	1.34
Long-Term Debt to EBITDA	0.95	1.48	2.46	1.70	3.29	2.65	5.60	2.29	5.59	4.40	2.86
Debt to NOPAT	1.40	2.14	3.57	2.49	4.77	3.92	9.17	3.58	8.91	6.74	4.08
Net Debt to NOPAT	-0.08	-1.69	0.58	-1.24	2.78	1.56	-19.39	-4.53	5.59	3.82	1.90
Long-Term Debt to NOPAT	1.40	2.14	3.57	2.49	4.77	3.92	9.17	3.58	8.91	6.74	4.08
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	39	72	-49	-96	-92	-61	-59	-11	-53	-60	-61
Operating Cash Flow to CapEx	120,666.67%	9,795.06%	636.70%	1,508.73%	324.91%	2,189.02%	2,707.22%	3,060.00%	2,726.71%	6,795.49%	2,859.13%
Free Cash Flow to Firm to Interest Expense	3.22	5.50	-3.57	-6.83	-7.21	-5.12	-4.81	-0.95	-5.14	-5.98	-5.94
Operating Cash Flow to Interest Expense	0.30	0.60	0.48	0.66	0.49	0.60	0.80	1.09	1.57	0.90	0.90
Operating Cash Flow Less CapEx to Interest Expense	0.30	0.60	0.40	0.61	0.34	0.58	0.77	1.06	1.52	0.89	0.87
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.04	0.04	0.04	0.03	0.04	0.04	0.03	0.03	0.03	0.04	0.04
Fixed Asset Turnover	6.45	6.48	6.40	6.36	6.29	6.53	5.70	5.97	5.99	6.35	7.94
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	230	250	285	274	328	317	338	293	389	386	407
Invested Capital Turnover	0.40	0.34	0.37	0.43	0.35	0.35	0.28	0.32	0.27	0.28	0.32
Increase / (Decrease) in Invested Capital	-35	-65	54	101	98	67	53	18	61	69	70
Enterprise Value (EV)	227	155	236	196	298	257	15	192	350	329	423
Market Capitalization	229	197	222	223	232	222	232	252	266	259	359
Book Value per Share	$41.34	$41.49	$42.34	$46.39	$45.25	$47.67	$49.05	$51.20	$53.13	$54.57	$56.09
Tangible Book Value per Share	$36.72	$36.90	$37.75	$41.81	$40.66	$43.12	$44.49	$46.65	$48.57	$50.04	$51.57
Total Capital	230	250	285	274	328	317	338	293	389	386	407
Total Debt	35	53	84	54	113	89	103	48	135	123	137
Total Long-Term Debt	35	53	84	54	113	89	103	48	135	123	137
Net Debt	-1.88	-42	14	-27	66	35	-217	-60	84	70	64
Capital Expenditures (CapEx)	0.00	0.08	1.02	0.61	1.92	0.33	0.36	0.40	0.60	0.13	0.32
Net Nonoperating Expense (NNE)	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00
Net Nonoperating Obligations (NNO)	35	53	84	54	113	89	103	48	135	123	137
Total Depreciation and Amortization (D&A)	1.25	0.61	1.27	1.29	1.12	1.17	1.18	0.86	0.95	0.88	0.92
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.80	$1.48	$1.05	$1.19	$1.24	$1.26	($1.35)	$1.62	$1.61	$1.91	$1.82
Adjusted Weighted Average Basic Shares Outstanding	4.73M	4.76M	4.77M	4.77M	4.77M	4.79M	4.81M	4.81M	4.80M	4.82M	4.84M
Adjusted Diluted Earnings per Share	$0.80	$1.48	$1.05	$1.19	$1.24	$1.26	($1.35)	$1.62	$1.61	$1.91	$1.82
Adjusted Weighted Average Diluted Shares Outstanding	4.73M	4.76M	4.77M	4.77M	4.77M	4.79M	4.81M	4.81M	4.80M	4.82M	4.84M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	4.75M	4.75M	4.76M	4.76M	4.79M	4.79M	4.79M	4.79M	4.82M	4.82M	4.82M
Normalized Net Operating Profit after Tax (NOPAT)	3.80	7.05	4.99	5.72	5.91	6.02	-6.17	7.79	7.74	9.20	8.81
Normalized NOPAT Margin	16.00%	29.69%	21.35%	23.53%	22.85%	23.43%	-61.05%	27.08%	25.37%	30.76%	28.26%
Pre Tax Income Margin	19.53%	38.27%	26.80%	29.76%	28.99%	29.90%	-87.21%	34.98%	36.02%	39.60%	36.22%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.38	0.69	0.46	0.52	0.59	0.65	-0.72	0.90	1.06	1.18	1.10
NOPAT to Interest Expense	0.31	0.54	0.37	0.41	0.46	0.51	-0.50	0.70	0.75	0.92	0.86
EBIT Less CapEx to Interest Expense	0.38	0.69	0.38	0.47	0.44	0.62	-0.75	0.86	1.00	1.17	1.07
NOPAT Less CapEx to Interest Expense	0.31	0.53	0.29	0.37	0.31	0.48	-0.53	0.66	0.69	0.91	0.83
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	23.36%	23.63%	24.98%	34.11%	31.11%	32.80%	66.83%	46.47%	41.88%	35.18%	19.49%
Augmented Payout Ratio	24.62%	24.84%	26.26%	35.54%	32.57%	34.34%	69.97%	49.13%	44.50%	37.83%	20.95%

Financials Breakdown Chart

Key Financial Trends

Chemung Financial (NASDAQ: CHMG) showed a sharp rebound in profitability in Q1 2026, but the balance sheet still reflects a bank that is managing a difficult mix of deposit volatility, lower liquidity, and higher leverage than it had a year ago.

On the income statement, Q1 2026 net income came in at $9.2 million, up from $7.7 million in Q4 2025 and well ahead of the weak Q2 2025 loss of $6.5 million. The rebound was driven by much better non-interest income and tighter operating control. Revenue rose to $29.9 million from $25.9 million in Q4 2025, while the provision for credit losses fell to $601,000 from $1.1 million.

That said, the prior year showed how sensitive results can be to market swings and balance-sheet positioning. Q2 2025 was especially weak because non-interest income was hit by a large negative mark in investment gains/losses, which pushed total revenue down to just $10.1 million and produced a quarterly loss. By contrast, Q1 2026 benefited from a much cleaner quarter and stronger core banking results.

Key positives

Q1 2026 net income of $9.2 million marked a strong recovery from the Q2 2025 loss.
Revenue improved to $29.9 million, supported by better non-interest income and stable net interest income.
Net interest income held up at $23.6 million in Q1 2026, roughly in line with recent quarters.
Provision for credit losses dropped to $601,000, suggesting less pressure from expected loan losses.
Operating cash flow was solid at $9.0 million in Q1 2026.
Retained earnings increased to $264.0 million, reflecting continued earnings accumulation over time.
Core deposit growth resumed in Q1 2026, with net change in deposits of $43.2 million.

Neutral items

Basic EPS in Q1 2026 was $1.91, up from $1.61 in Q4 2025, but the improvement is coming off an unusually weak comparison period.
The bank continues to carry meaningful goodwill of $21.8 million, which is common for an acquisitive bank but worth watching.
Total assets rose modestly to $2.75 billion from $2.70 billion in Q3 2025.
Loan growth remains steady, with gross loans and leases rising to $2.31 billion from $2.20 billion in Q3 2025.

Key negatives

Liquidity appears lower than it was earlier in the year, with cash and due from banks falling to $27.7 million from $32.4 million in Q3 2025 and far below the large cash position seen in early 2025.
Long-term debt increased to $119.8 million in Q1 2026 from $44.0 million in Q3 2025, raising leverage.
Total common equity rose to only $262.9 million versus $245.3 million in Q3 2025, leaving tangible balance-sheet support relatively thin for a bank of this size.
Deposits remain somewhat volatile quarter to quarter, which can pressure funding costs and balance-sheet stability.
The company’s results have been choppy over the last year, including a sizable loss in Q2 2025 and a steep drop in net change in cash in multiple quarters.
Interest expense remains elevated, with Q1 2026 deposit interest expense at $8.5 million, limiting margin expansion.

Overall, CHMG looks like a bank that has recovered earnings momentum after a difficult middle of 2025, but investors should keep an eye on funding stability, leverage, and liquidity. The latest quarter was encouraging, yet the balance sheet still suggests a company that needs to manage its deposit base carefully to sustain the rebound.

08/17/26 01:12 AM ETAI Generated. May Contain Errors.

Chemung Financial Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Chemung Financial's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Chemung Financial's net income appears to be on an upward trend, with a most recent value of $15.10 million in 2025, rising from $9.43 million in 2015. The previous period was $23.67 million in 2024. See where experts think Chemung Financial is headed by visiting Chemung Financial's forecast page.

Over the last 10 years, Chemung Financial's total revenue changed from $71.09 million in 2015 to $95.10 million in 2025, a change of 33.8%.

Chemung Financial's total liabilities were at $2.46 billion at the end of 2025, a 4.1% decrease from 2024, and a 65.6% increase since 2015.

In the past 10 years, Chemung Financial's cash and equivalents has ranged from $22.25 million in 2023 to $44.35 million in 2021, and is currently $22.77 million as of their latest financial filing in 2025.

Over the last 10 years, Chemung Financial's book value per share changed from 29.44 in 2015 to 53.13 in 2025, a change of 80.4%.

Related Companies

Financial statements for NASDAQ:CHMG last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chemung Financial (CHMG) Financials

Financials Breakdown Chart

Key Financial Trends

Chemung Financial Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Chemung Financial (CHMG) Financials

Annual Income Statements for Chemung Financial

Quarterly Income Statements for Chemung Financial

Annual Cash Flow Statements for Chemung Financial

Quarterly Cash Flow Statements for Chemung Financial

Annual Balance Sheets for Chemung Financial

Quarterly Balance Sheets for Chemung Financial

Annual Metrics And Ratios for Chemung Financial

Quarterly Metrics And Ratios for Chemung Financial

Financials Breakdown Chart

Key Financial Trends

Chemung Financial Financials - Frequently Asked Questions

When does Chemung Financial's financial year end?

How has Chemung Financial's net income changed over the last 10 years?

How has Chemung Financial's revenue changed over the last 10 years?

How much debt does Chemung Financial have?

How much cash does Chemung Financial have?

How has Chemung Financial's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools